HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenichi Sugihara Selected Research

Capecitabine (Xeloda)

6/2017Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer.
1/2017Erratum to: Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer.
11/2013[A case of recurrent rectal cancer successfully treated for a long period with capecitabine plus oxaliplatin and bevacizumab therapy].
11/2012[A case report of stage IV cecal cancer exhibiting a complete response to multidisciplinary therapy].
11/2012[A case of metastatic breast cancer with bilateral hydronephrosis effectively treated with capecitabine].
11/2012[A long-surviving case of HER2-positive breast cancer with brain metastasis treated by multidisciplinary therapy].
11/2011[A case of breast cancer liver metastases responding to lapatinib and capecitabine therapy].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenichi Sugihara Research Topics

Disease

122Neoplasms (Cancer)
08/2022 - 01/2002
90Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 05/2002
70Neoplasm Metastasis (Metastasis)
06/2022 - 07/2002
47Colonic Neoplasms (Colon Cancer)
06/2022 - 12/2003
32Stomach Neoplasms (Stomach Cancer)
12/2015 - 10/2004
26Rectal Neoplasms (Rectal Cancer)
06/2022 - 06/2003
22Breast Neoplasms (Breast Cancer)
09/2016 - 03/2005
21Lymphatic Metastasis
08/2022 - 01/2002
13Adenocarcinoma
08/2020 - 10/2003
10Carcinogenesis
01/2017 - 05/2002
8Carcinoma (Carcinomatosis)
01/2010 - 01/2002
7Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
06/2017 - 09/2002
5Hemorrhage
10/2014 - 11/2013
4Microsatellite Instability
12/2020 - 10/2006
4Anastomotic Leak
03/2020 - 12/2013
4Liver Diseases (Liver Disease)
11/2012 - 11/2009
3Neutropenia
08/2020 - 09/2013
3Pneumonia (Pneumonitis)
01/2017 - 06/2013
3Weight Loss (Weight Reduction)
08/2015 - 04/2014
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2014 - 04/2007
3Chronic Obstructive Pulmonary Disease (COPD)
08/2014 - 06/2013
3Adenoma (Adenomas)
12/2003 - 09/2002
2Mucinous Adenocarcinoma (Mucinous Carcinoma)
10/2020 - 10/2003
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2018 - 11/2010
2Aggressive Fibromatosis (Desmoid)
08/2016 - 11/2014
2Noninfiltrating Intraductal Carcinoma (DCIS)
05/2016 - 12/2012
2Margins of Excision
05/2016 - 10/2003
2Peritonitis
01/2016 - 10/2015

Drug/Important Bio-Agent (IBA)

26Messenger RNA (mRNA)IBA
01/2017 - 01/2002
20Fluorouracil (Carac)FDA LinkGeneric
08/2020 - 11/2003
17Leucovorin (Folinic Acid)FDA Link
08/2020 - 02/2003
14Bevacizumab (Avastin)FDA Link
08/2020 - 10/2008
14Oxaliplatin (Eloxatin)FDA LinkGeneric
08/2020 - 12/2008
14Proteins (Proteins, Gene)FDA Link
09/2016 - 06/2003
11Carcinoembryonic AntigenIBA
01/2021 - 06/2003
10Biomarkers (Surrogate Marker)IBA
10/2020 - 05/2008
10Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2009 - 05/2002
9Cetuximab (Erbitux)FDA Link
06/2022 - 11/2009
9TegafurIBA
01/2020 - 02/2003
8Irinotecan (Camptosar)FDA LinkGeneric
01/2015 - 11/2003
7UracilIBA
01/2020 - 02/2003
7Capecitabine (Xeloda)FDA Link
06/2017 - 11/2011
6Biological ProductsIBA
01/2022 - 12/2002
6Hormones (Hormone)IBA
05/2016 - 12/2005
6DNA (Deoxyribonucleic Acid)IBA
03/2016 - 09/2005
6Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
01/2015 - 07/2002
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2009 - 03/2005
5Calcibiotic Root Canal SealerIBA
01/2021 - 09/2005
5Pharmaceutical PreparationsIBA
11/2014 - 06/2005
4Indicators and Reagents (Reagents)IBA
10/2020 - 12/2004
4Panitumumab (Vectibix)FDA Link
11/2014 - 12/2012
4Estrogen ReceptorsIBA
11/2013 - 03/2005
4Paclitaxel (Taxol)FDA LinkGeneric
11/2013 - 11/2009
4ErbB Receptors (EGF Receptor)IBA
11/2013 - 12/2008
4EnzymesIBA
03/2013 - 06/2003
4RNA (Ribonucleic Acid)IBA
06/2012 - 12/2008
4DecitabineFDA Link
03/2012 - 01/2005
4ParaffinIBA
04/2009 - 01/2003
4Formaldehyde (Formol)FDA Link
04/2009 - 01/2003
4Thymidylate SynthaseIBA
07/2008 - 02/2003
4Thymidine PhosphorylaseIBA
07/2008 - 05/2004
4Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
09/2007 - 10/2003
3Therapeutic UsesIBA
07/2021 - 01/2004
3AntigensIBA
01/2016 - 12/2003
3Phosphotransferases (Kinase)IBA
10/2015 - 06/2013
3Serum AlbuminIBA
08/2015 - 01/2013
3Zoledronic Acid (Zometa)FDA Link
11/2013 - 11/2012
3Tumor Biomarkers (Tumor Markers)IBA
11/2013 - 01/2007
3Trastuzumab (Herceptin)FDA Link
11/2012 - 11/2011
3MicroRNAs (MicroRNA)IBA
06/2012 - 04/2008
3Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
12/2004 - 10/2003
2CarbohydratesIBA
11/2020 - 01/2016
2regorafenibIBA
01/2019 - 01/2018
2titanium silicide (TS-1)IBA
01/2018 - 03/2016
2KinesinsIBA
09/2016 - 12/2011
2Alkaline PhosphataseIBA
08/2015 - 12/2014
2CreatinineIBA
08/2015 - 04/2014
2tyrosine receptor (receptor, tyrosine)IBA
07/2015 - 06/2013
2ErythropoietinFDA Link
07/2015 - 06/2013

Therapy/Procedure

59Drug Therapy (Chemotherapy)
06/2022 - 07/2002
44Therapeutics
07/2021 - 06/2003
26Adjuvant Chemotherapy
01/2021 - 01/2004
25Lymph Node Excision (Lymph Node Dissection)
08/2022 - 10/2009
25Gastrectomy
01/2016 - 10/2004
17Colectomy
01/2022 - 09/2004
11Hepatectomy
11/2020 - 10/2003
9Lasers (Laser)
06/2012 - 06/2005
7Radiotherapy
03/2022 - 11/2011
6Operative Surgical Procedures
08/2022 - 11/2010
6Chemoradiotherapy
07/2021 - 03/2013
5Restorative Proctocolectomy
06/2017 - 01/2014
4Proctectomy
06/2022 - 11/2009
4Ligation
11/2021 - 01/2011
3Hyperthermic Intraperitoneal Chemotherapy
03/2021 - 01/2010
3Laparotomy
01/2021 - 11/2003
3Activities of Daily Living (ADL)
08/2015 - 04/2014
3Colostomy
11/2013 - 11/2010
2Combined Modality Therapy
09/2016 - 11/2013
2Metastasectomy
09/2016 - 11/2010
2Esophagectomy
01/2016 - 07/2012